Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants.

about

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants.

Item

http://www.wikidata.org/entity/Q45324676

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@en

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@nl

type

Item

label

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@en

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@nl

prefLabel

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@en

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@nl

P1476

Trends in Utilization of Outpa ...... Commercially Insured Infants.

@en

P2093

Amanda M Kong

http://www.w3.org/2001/XMLSchema#string

Kimmie K McLaurin

http://www.w3.org/2001/XMLSchema#string

Melissa Pavilack

http://www.w3.org/2001/XMLSchema#string

Robert A Clifford

http://www.w3.org/2001/XMLSchema#string

Sally Wade

http://www.w3.org/2001/XMLSchema#string

Tara Gonzales

http://www.w3.org/2001/XMLSchema#string

P2860

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis.

The burden of respiratory syncytial virus infection in young children

Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.

Respiratory syncytial virus--United States, July 2012-June 2014.

Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.

Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.

Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999.

P2888

s40121-017-0178-6

P304

121-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-017-0178-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092753962

http://www.w3.org/2001/XMLSchema#string

P698

29149439

http://www.w3.org/2001/XMLSchema#string

P932

5840097

http://www.w3.org/2001/XMLSchema#string